Código QR (código de barras bidimensional)

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

Abstract Background For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compared with enalapril alone. Whether folic acid therap...

ver descrição completa

Na minha lista:
Principais autores: Tiantian Zhang, Zhuoru Liang, Tengfei Lin, David J. Cohen, Alejandro Arrieta, Xiaobin Wang, Xianhui Qin, Binyan Wang, Yong Huo, Gordon G. Liu, Jie Jiang, Zugui Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-10-01
coleção:BMC Medicine
Assuntos:
Cost-effectiveness
Folic acid
Primary prevention
Stroke
Hypertension
Acesso em linha:https://doi.org/10.1186/s12916-022-02601-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados